Alberta Lung has been a leader in the fight for healthy lungs and air since the 1930s. Whether searching for treatments or cures to prevent or treat lung diseases, keeping kids free from tobacco and e-cigarettes, or fighting for laws that protect the air we all breathe, Alberta Lung continues its quest for better health.

1892

Asthma is characterized as an inflammatory disease.

1907

We were known as the Alberta Tuberculosis Society. For much of the 20th century, we played a critical role in funding weapons to prevent, detect and treat TB.

1914

First public health vaccines produced.

Field of thoracic surgery developed.

1933

Kinsmen began selling Christmas Seals to fund tuberculosis treatment and screening efforts

1939

Incorporated as the Alberta Tuberculosis Association

1940

Pulmonary damage caused by smoking identified.

Early diagnosis of TB found through chest x-rays.

1942

First mobile chest x-ray unit in Alberta to provide free chest x-rays

Field of thoracic surgery developed.

1967

We changed our name to the Alberta Lung Association. Tuberculosis (TB) rates had declined. Other lung diseases, especially those linked to cigarette smoking, were on the rise. We recognized the need to address the entire scope of respiratory diseases.

1970

First successful trials of cyclosporine, an anti-rejection drug used in lung transplants.

1970s

Thanks to advances in research leading to fewer patients, dedicated TB hospitals were no longer necessary. Patients could be treated with new drugs at home or in hospitals.

1983

First successful single lung transplant.

1998

Discovery of the gene that causes cystic fibrosis.

2003

Development of the draft sequence of the SARS virus.

2021

We ended the membership agreement with the Canadian Lung Association. This allowed us to maximize our investments in much-needed support, education, and programs for lung patients and families in Alberta and across Canada.

TODAY

Today, we are strong advocates for the protection of our children from the harmful effects of tobacco and vaping. We promote immunization, support families, and fund critical research. We continue our efforts to prevent lung disease and promote lung health, addressing new and emerging threats including COVID-19.